Please login to the form below

Aptalis

This page shows the latest Aptalis news and features for those working in and with pharma, biotech and healthcare.

HIV prevention pill heads July CHMP recommendations

Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

Latest news

Actavis claims top UK generics spot with Auden Mckenzie buy

Other acquisitions in the last 12 months have included $25bn for Forest Laboratories, $2.9bn for Aptalis, a $1.6bn deal for Furiex Pharma and $675m for Durata.
Forest Labs agrees $1.46bn deal to buy Furiex

Forest chief executive Brent Saunders said the Furiex deal "is a natural extension of our GI business following our $2.9bn acquisition of Aptalis earlier this year," adding that eluxadoline would
Forest said to be interested in $3bn Aptalis acquisition

Forest said to be interested in $3bn Aptalis acquisition. Deal would give pharma company ownership of cystic fibrosis and gastrointestinal products. ... The Aptalis rumour also comes shortly after Forest itself was the subject of speculation about a
Par Pharma acquired by investment firm for $1.9bn

TPG has several major healthcare investments already, with stakes in firms such as Aptalis Pharma, Biomet, Immucor, IMS Health and Quintiles Transnational, and the acquisition of Par provides the company with

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2014

The deal is expected to close mid 2014, pending approvals. The announcement came just after Forest completed its acquisition of Aptalis last month for $3bn and this month sold a number
Pharma deals during January 2014

Almost right to the end of the month, the big headline deal was that of Forest with its planned takeover of Aptalis. ... Aptalis itself was only formed in 2011 following the acquisition of Eurand by the Montreal based Axcan Pharma.
Deal Watch table for January 2014

4, 295. Aptalis/ Forest. Company acquisition. Acquiring sales turnover of $688m. 2, 900.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

He has held numerous leadership roles including president and CEO of Aptalis Pharma prior to its acquisition by Forest Laboratories.
Lupin names chief corporate development officer

Lupin names chief corporate development officer. Theresa Stevens has experience at Novartis and Aptalis. ... Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions,
Marino Garcia joins Synergy Pharmaceuticals

Marino Garcia joins Synergy Pharmaceuticals. He has experience in gastrointestinal market at Aptalis. ... Prior to his time at Aptalis Garcia was VP of US commercial operations and new product development at Aspreva Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Sudler London - Account Director: Competitive

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Associate Scientific Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Sudler London - Senior Medical Writer: Competitive

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Account Manager: Negotiable

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Director, Healthcare Advertising Agency: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Writer, Healthcare Advertising, London: Excellent package

Market Access Consultant - Greater Manchester: Negotiable

Medical Writers Required - Hertfordshire: Competitive

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Subscribe to our email news alerts

PMHub

Add my company

OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....